Related Experiment Videos
Analysis of gene expression profiles in pancreatic carcinoma by using cDNA microarray
Xian-Jun Yu1, Jiang Long, De-Liang Fu
1Center for Pancreatic Cancer, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China. yuxianjun@hotmail.com
Hepatobiliary & Pancreatic Diseases International : HBPD INT
|November 6, 2003
Summary
This study used cDNA microarray to survey gene expression in pancreatic carcinoma, identifying 455 differentially expressed genes. Key genes and mechanisms like MBD1 and EDG1 were highlighted for their role in pancreatic cancer development.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Pancreatic carcinoma is a significant health concern with complex genetic underpinnings.
- Understanding gene expression profiles is crucial for identifying novel therapeutic targets.
Purpose of the Study:
- To investigate gene expression profiles in pancreatic carcinoma using cDNA microarray.
- To identify differentially expressed genes and potential therapeutic targets in pancreatic cancer.
Main Methods:
- Utilized cDNA microarray technology to analyze gene expression.
- Compared gene expression between normal pancreatic tissue and pancreatic carcinoma samples.
- Examined 18,000 genes across multiple patient samples.
Main Results:
- Identified 1484 and 1353 differentially expressed genes in two cancer samples.
- Pinpointed 455 genes with consistent expression changes, including 102 up-regulated and 353 down-regulated.
- Detected alterations in tumor suppressor genes, growth factors, receptor genes, signal conduction genes, and transcription factors.
Conclusions:
- cDNA microarray is an effective high-throughput method for profiling pancreatic carcinoma gene expression.
- MBD1, EDG1, and gene hypermethylation mechanisms are implicated in pancreatic cancer pathogenesis.
- The study identified potential molecular targets for further investigation in pancreatic cancer.